RBC Bioscience

RBC Bioscience Inventory

The Inventory of RBC Bioscience (6848.TWO) as of Nov 5, 2026 is 52.76 M TWD. In the previous year, Inventory was 44.42 M TWD — a change of 18.77% (higher).

Inventory

52.76 MTWD

YoY

18.77%

Last updated:

Inventory of RBC Bioscience is 2024 52.76 M TWD. Inventory of RBC Bioscience was 2023 44.42 M TWD. It decreases by 18.77% higher compared to the previous year.

The RBC Bioscience Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
28.06 M TWD
Jan 1, 2019
25.14 M TWD
Jan 1, 2020
60.78 M TWD
Jan 1, 2021
51.20 M TWD
Jan 1, 2022
47.20 M TWD
Jan 1, 2023
44.42 M TWD
Jan 1, 2024
52.76 M TWD
The RBC Bioscience Inventory history
YEARInventoryYoY
52.76 MTWD+18.77%
44.42 MTWD-5.88%
47.20 MTWD-7.81%
51.20 MTWD-15.77%
60.78 MTWD+141.81%
25.14 MTWD-10.43%
28.06 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Inventory of RBC Bioscience is 52.76 M TWD in 2024.

Inventory of RBC Bioscience changed from 44.42 M TWD to 52.76 M TWD, representing a 18.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RBC Bioscience

All Key Metrics — RBC Bioscience